Cargando…

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation

INTRODUCTION: Lenvatinib is approved for the treatment of patients with metastatic or recurrent hepatocellular carcinoma (HCC); however, clinical outcomes of lenvatinib therapy in patients with post‐liver transplantation (LT) HCC recurrence remain unclear. We investigated the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bang, Kyunghye, Casadei‐Gardini, Andrea, Yoo, Changhoon, Iavarone, Massimo, Ryu, Min‐Hee, Park, Sook Ryun, Kim, Hyung‐Don, Yoon, Young‐In, Jung, Dong‐Hwan, Park, Gil‐Chun, Ahn, Chul‐Soo, Moon, Deok‐Bog, Hwang, Shin, Kim, Ki‐Hun, Song, Gi‐Won, Mazzarelli, Chiara, Alimenti, Eleonora, Chan, Stephen L., De Giorgio, Massimo, Ryoo, Baek‐Yeol, Lee, Sung‐Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939097/ https://www.ncbi.nlm.nih.gov/pubmed/36812124 http://dx.doi.org/10.1002/cam4.5123

Ejemplares similares

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
por: Bang, Kyunghye, et al.
Publicado: (2021)

Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation
por: Chung, Yong-Kyu, et al.
Publicado: (2018)

Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
por: Lee, Kyoungmin, et al.
Publicado: (2020)

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
por: Choi, Won-Mook, et al.
Publicado: (2020)

Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
por: Burgio, Valentina, et al.
Publicado: (2021)

Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma
por: Jeon, Seung Hyuck, et al.
Publicado: (2022)

Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study
por: Park, Kwonoh, et al.
Publicado: (2017)

Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
por: Bang, Yeong Hak, et al.
Publicado: (2022)

Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
por: Kim, Bum Jun, et al.
Publicado: (2017)

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY
por: Kim, Jwa Hoon, et al.
Publicado: (2022)

Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors
por: Yoo, Changhoon, et al.
Publicado: (2016)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
por: Yoo, Changhoon, et al.
Publicado: (2019)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
por: Son, Myoung Kyun, et al.
Publicado: (2017)

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
por: Hyung, Jaewon, et al.
Publicado: (2019)

Conjoined unification venoplasty for triple portal vein branches of right liver graft: a case report and technical refinement
por: Kwon, Jae Hyun, et al.
Publicado: (2016)

Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review
por: Jung, Dong-Hwan, et al.
Publicado: (2015)

Calculation of standard liver volume in Korean adults with analysis of confounding variables
por: Um, Eun Hae, et al.
Publicado: (2015)

Liver retransplantation for adult recipients
por: Hwang, Shin, et al.
Publicado: (2013)

Standardized surgical techniques for adult living donor liver transplantation using a modified right lobe graft: a video presentation from bench to reperfusion
por: Hwang, Shin, et al.
Publicado: (2016)

A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asan Medical Center: Increased preference for mycophenolate mofetil
por: Hwang, Shin, et al.
Publicado: (2018)

Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy
por: Hwang, Shin, et al.
Publicado: (2017)

Pneumatosis intestinalis after adult living donor liver transplantation: report of three cases and collective literature review
por: Park, Cheon-Soo, et al.
Publicado: (2015)

Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen
por: Yoo, Changhoon, et al.
Publicado: (2017)

Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
por: Park, Sook Ryun, et al.
Publicado: (2016)

Tumour-to-liver ratio determined by [(68)Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
por: Kim, Yong-il, et al.
Publicado: (2020)

Patency of Hemashield grafts versus ringed Gore-Tex grafts in middle hepatic vein reconstruction for living donor liver transplantation
por: Kim, Sang Hoon, et al.
Publicado: (2021)

A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer
por: Ryu, Min‐Hee, et al.
Publicado: (2017)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct
por: Jang, Gi-Woong, et al.
Publicado: (2012)

A central role for PI3K-AKT signaling pathway in linking SAMHD1-deficiency to the type I interferon signature
por: Oh, Changhoon, et al.
Publicado: (2018)

Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers
por: Seo, Seyoung, et al.
Publicado: (2016)

Radiation therapy for recurrent extrahepatic bile duct cancer
por: Koh, Minji, et al.
Publicado: (2021)

Technical knacks and outcomes of extended extrahepatic bile duct resection in patients with mid bile duct cancer
por: Lee, Seung-Jae, et al.
Publicado: (2013)

Prolonged occlusion of the hepatoduodenal ligament to reduce risk of bleeding and tumor spread during recipient hepatectomy for living donor liver transplantation
por: Choi, Jin-Uk, et al.
Publicado: (2019)

Living donor liver transplantation for diffuse biliary papillomatosis with malignant change: A case report with 10-year follow-up
por: Choi, Jin Uk, et al.
Publicado: (2020)

Living donor liver transplantation for unresectable colorectal liver metastasis: Report of a case with 13-year follow-up without recurrence
por: Choi, Jin Uk, et al.
Publicado: (2020)

Institutional standard framework and experience of living donor liver transplantation for overseas non-Korean patients at Asan Medical Center
por: Kim, Sang-Hoon, et al.
Publicado: (2021)

Evolution of the technique of renoportal anastomosis for patients with complete portal venous occlusion in living donor liver transplantation: a retrospective cohort study
por: Yoon, Young-In, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7buad9v4qmh7cjrms5qda3ndit